What intravenous hydrocortisone dose and frequency should be used for a moderate to severe hypersensitivity reaction in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hydrocortisone Dosing for Moderate to Severe Hypersensitivity Reactions

For moderate to severe hypersensitivity reactions (anaphylaxis), administer intravenous hydrocortisone (or equivalent methylprednisolone) at a dose of 1.0 to 2.0 mg/kg/day divided every 6 hours in both adults and children. This translates to approximately 100 mg every 6 hours for adults, or a total daily dose of 200-400 mg depending on body weight 1.

Adult Dosing

For adults experiencing severe or prolonged anaphylaxis:

  • Dose: 1.0-2.0 mg/kg/day of hydrocortisone (or equivalent methylprednisolone)
  • Frequency: Every 6 hours via intravenous administration
  • Practical application: This typically means 100 mg IV every 6 hours for an average adult, totaling 400 mg/day 1

The 2017 ESMO guidelines for infusion reactions align with this approach, recommending an equivalent dose to 1-2 mg/kg of IV methylprednisolone every 6 hours for both anaphylaxis and severe hypersensitivity reactions 2.

Pediatric Dosing

For children with severe hypersensitivity reactions:

  • Dose: 1.0-2.0 mg/kg/day of hydrocortisone
  • Frequency: Every 6 hours via IV administration
  • Alternative: 2 mg/kg every 6-8 hours IM or SC, or every 6 hours via IV drip depending on clinical state 1, 3

Critical Context and Timing

Glucocorticoids are NOT first-line therapy for anaphylaxis and should never be used alone. Epinephrine remains the primary treatment 1. Corticosteroids have a delayed onset of action and are not helpful acutely, but they potentially prevent recurrent or protracted anaphylaxis (biphasic reactions) 1.

When to Consider Corticosteroids

Systemic glucocorticosteroids should be considered specifically for:

  • Patients with a history of idiopathic anaphylaxis
  • Patients with asthma experiencing anaphylaxis
  • Patients experiencing severe or prolonged anaphylaxis 1

Alternative for Less Severe Reactions

For less critical anaphylactic episodes, oral prednisone at 0.5 mg/kg may be sufficient 1. However, for moderate to severe reactions requiring IV therapy, the full dose regimen should be used.

Important Caveats

Pharmacokinetic considerations: Hydrocortisone sodium succinate administered IV demonstrates effects within one hour, with excretion nearly complete within 12 hours 4. Research shows that hydrocortisone concentrations decrease with a half-life of approximately 1.24 hours after IV administration 5. This supports the every 6-hour dosing interval to maintain therapeutic levels.

Paradoxical reactions: While rare, be aware that corticosteroids themselves can paradoxically cause hypersensitivity reactions, including anaphylaxis 6, 7. If a patient deteriorates after hydrocortisone administration rather than stabilizes, consider this possibility and discontinue immediately.

Route matters: The guidelines consistently specify intravenous administration for acute severe reactions. Intramuscular or subcutaneous routes are alternatives only when IV access is unavailable or in specific clinical contexts 3.

Duration: Continue the every-6-hour regimen until clinical stability is achieved, then consider transitioning to oral corticosteroids with gradual tapering over several days 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.